[go: up one dir, main page]

FR2587700B1 - 2-oxo-1-(((sulfonyl substitue)amino)carbonyl)azetidines a action therapeutique - Google Patents

2-oxo-1-(((sulfonyl substitue)amino)carbonyl)azetidines a action therapeutique

Info

Publication number
FR2587700B1
FR2587700B1 FR8613466A FR8613466A FR2587700B1 FR 2587700 B1 FR2587700 B1 FR 2587700B1 FR 8613466 A FR8613466 A FR 8613466A FR 8613466 A FR8613466 A FR 8613466A FR 2587700 B1 FR2587700 B1 FR 2587700B1
Authority
FR
France
Prior art keywords
azetidines
sulfonyl
oxo
carbonyl
substitute
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8613466A
Other languages
English (en)
French (fr)
Other versions
FR2587700A1 (fr
Inventor
Hermann Breuer
Uwe D Treuner
William H Koster
Robert Zahler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2587700A1 publication Critical patent/FR2587700A1/fr
Application granted granted Critical
Publication of FR2587700B1 publication Critical patent/FR2587700B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR8613466A 1985-09-26 1986-09-26 2-oxo-1-(((sulfonyl substitue)amino)carbonyl)azetidines a action therapeutique Expired FR2587700B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78047985A 1985-09-26 1985-09-26

Publications (2)

Publication Number Publication Date
FR2587700A1 FR2587700A1 (fr) 1987-03-27
FR2587700B1 true FR2587700B1 (fr) 1988-09-16

Family

ID=25119699

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8613466A Expired FR2587700B1 (fr) 1985-09-26 1986-09-26 2-oxo-1-(((sulfonyl substitue)amino)carbonyl)azetidines a action therapeutique

Country Status (31)

Country Link
JP (1) JPS6284082A (ja)
KR (1) KR900001013B1 (ja)
CN (1) CN86106980A (ja)
AT (1) ATA257986A (ja)
AU (1) AU600912B2 (ja)
BE (1) BE905502A (ja)
CA (1) CA1308719C (ja)
CH (1) CH670828A5 (ja)
DD (1) DD250121A5 (ja)
DE (1) DE3632876A1 (ja)
DK (1) DK460386A (ja)
EG (1) EG18314A (ja)
ES (1) ES2001995A6 (ja)
FI (1) FI863890A (ja)
FR (1) FR2587700B1 (ja)
GB (1) GB2181130B (ja)
GR (1) GR862449B (ja)
HU (1) HU198044B (ja)
IE (1) IE59686B1 (ja)
IL (1) IL80160A (ja)
IT (1) IT1214533B (ja)
LU (1) LU86611A1 (ja)
NL (1) NL8602446A (ja)
NO (1) NO863837L (ja)
NZ (1) NZ217704A (ja)
PH (1) PH23315A (ja)
PL (1) PL151546B1 (ja)
PT (1) PT83440B (ja)
SE (1) SE8604089L (ja)
YU (1) YU46177B (ja)
ZA (1) ZA867373B (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7541487A (en) * 1986-05-23 1987-12-22 Upjohn Company, The N-1 substituted sulfonylaminocarbonyl, c-4 substituted monobactams
WO1988006156A1 (en) * 1987-02-11 1988-08-25 The Upjohn Company NOVEL N-1 SUBSTITUTED beta-LACTAMS AS ANTIBIOTICS
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
AU600094B2 (en) * 1987-02-27 1990-08-02 Upjohn Company, The Antibiotic 2- azetidinones have pyrid -4- one 2-yl- carbonylamino-1-imidazolid-2-one-3-yl sulfonylaminocarbonyl groups at N-1
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US4772693A (en) * 1987-07-01 1988-09-20 E. R. Squibb & Sons, Inc. 2-oxo-1-((Substituted sulfonyl)amino)-carbonyl)azetidines
US4762922A (en) * 1987-07-01 1988-08-09 Squibb Corporation 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
AU2125188A (en) * 1987-07-22 1989-02-13 Upjohn Company, The Therapeutically useful beta-lactams
US4777252A (en) * 1987-08-13 1988-10-11 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4889930A (en) * 1987-12-21 1989-12-26 E. R. Squibb & Sons, Inc. Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein
US4871841A (en) * 1987-12-23 1989-10-03 E. R. Squibb & Sons, Inc. 2-Oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
EP0336667A3 (en) * 1988-04-04 1991-04-10 E.R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]-amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
US4959470A (en) * 1988-08-17 1990-09-25 E. R. Squibb & Sons, Inc. 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines
DE69325083T2 (de) * 1992-12-23 1999-10-28 Novartis Ag, Basel Imidazol-Derivate und ihre Verwendung als agrochemische Mittel
EP0671654B1 (en) * 1994-03-11 1997-09-10 Agfa-Gevaert N.V. Photographic material containing a new type of hydrazide
EP2308562B1 (en) * 2003-12-25 2015-02-25 Ono Pharmaceutical Co., Ltd. Azetidine ring compounds and drugs comprising the same
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
US9212147B2 (en) 2011-11-15 2015-12-15 Takeda Pharmaceutical Company Limited Dihydroxy aromatic heterocyclic compound
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
CN106986820B (zh) * 2017-02-24 2019-05-21 浙江工商大学 多功能的羟基吡啶酮衍生物及其水合物的制备法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199981A (en) * 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines
CA1272726C (en) * 1982-01-04 1990-08-14 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs
US4801705A (en) * 1986-06-23 1989-01-31 E. R. Squibb & Sons, Inc. 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines

Also Published As

Publication number Publication date
YU165986A (en) 1988-06-30
GB2181130B (en) 1989-09-20
EG18314A (en) 1993-02-28
DK460386A (da) 1987-03-27
PT83440B (pt) 1989-05-12
PL151546B1 (en) 1990-09-28
ATA257986A (de) 1994-07-15
PT83440A (pt) 1986-10-01
CN86106980A (zh) 1987-04-08
IE862547L (en) 1987-03-26
AU600912B2 (en) 1990-08-30
PH23315A (en) 1989-07-14
AU6315686A (en) 1987-04-02
JPS6284082A (ja) 1987-04-17
SE8604089L (sv) 1987-03-27
NZ217704A (en) 1989-02-24
GB2181130A (en) 1987-04-15
IL80160A (en) 1991-04-15
FI863890A (fi) 1987-03-27
KR900001013B1 (ko) 1990-02-24
IT1214533B (it) 1990-01-18
GB8623151D0 (en) 1986-10-29
DE3632876A1 (de) 1987-04-02
NO863837L (no) 1987-03-27
KR870003101A (ko) 1987-04-15
SE8604089D0 (sv) 1986-09-26
FI863890A0 (fi) 1986-09-26
CA1308719C (en) 1992-10-13
HU198044B (en) 1989-07-28
NL8602446A (nl) 1987-04-16
ZA867373B (en) 1987-05-27
NO863837D0 (no) 1986-09-26
LU86611A1 (fr) 1987-04-02
DK460386D0 (da) 1986-09-26
GR862449B (en) 1987-01-27
ES2001995A6 (es) 1988-07-01
BE905502A (fr) 1987-01-16
IE59686B1 (en) 1994-03-23
PL261575A1 (en) 1988-07-21
IT8621834A0 (it) 1986-09-26
HUT44535A (en) 1988-03-28
FR2587700A1 (fr) 1987-03-27
IL80160A0 (en) 1986-12-31
DD250121A5 (de) 1987-09-30
YU46177B (sh) 1993-05-28
CH670828A5 (ja) 1989-07-14

Similar Documents

Publication Publication Date Title
FR2587700B1 (fr) 2-oxo-1-(((sulfonyl substitue)amino)carbonyl)azetidines a action therapeutique
DK540289A (da) Protein
DK530787D0 (da) Indretning til indfoering i en legemshulhed
FI892507L (fi) Terapeutiska peptider.
FR2620711B1 (fr) Phosphinylcycloalkylcarbonyl et phosphinylcycloalcenylcarbonyl dipeptides a action therapeutique
AU2091988A (en) 2-oxo-1-(((substituted sulfonyl)amino)carbonyl)-azetidines
DK275788D0 (da) Protein
ZA883428B (en) Proteins having a tnf action
DK587687D0 (da) Blodudtagnings- og injektionsaggregat
GB8817456D0 (en) Flow injection analysis
BR8602642A (pt) Valvula de injecao
DK197989A (da) Peptidanaloger
FR2564845B1 (fr) Mercaptocycloalkylcarbonyl et mercaptoarylcarbonyl dipeptides a action therapeutique
GB8702171D0 (en) Protein hydrolysates
DE3664715D1 (en) Improved protein hydrolysate
DK395288D0 (da) Proteiner
FR2617483B1 (fr) 2-oxo-1-(((sulfonyl substitue)amino)-carbonyl)azetidines a action therapeutique
FR2617482B1 (fr) 2-oxo-1-(((sulfonyl substitue)amino)-carbonyl)azetidines a action therapeutique
KR900700503A (ko) 펩티드
FR2533566B1 (fr) Imino- et amino-acides acyloxycetone-substitues a action therapeutique
DK354989D0 (da) Modificerede proteiner
DK284489D0 (da) Fusionsproteiner
GB8816095D0 (en) Protein
FI883570A (fi) Kirurgisk termoplastsutur.
ZA889036B (en) 2-oxo-1-(((substituted sulfonyl)amino)carbonyl)azetidines

Legal Events

Date Code Title Description
ST Notification of lapse